ArticlePloS one2020

Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells.

Molly DiScala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.